CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy

趋化因子 归巢(生物学) CXCR4型 趋化性 免疫学 血管生成 趋化因子受体 免疫系统 生物 癌症 转移 癌症研究 受体 生态学 遗传学 生物化学
作者
Ashraf Sadat Mousavi
出处
期刊:Immunology Letters [Elsevier BV]
卷期号:217: 91-115 被引量:116
标识
DOI:10.1016/j.imlet.2019.11.007
摘要

Chemokines are small molecules called “chemotactic cytokines” and regulate many processes like leukocyte trafficking, homing of immune cells, maturation, cytoskeletal rearrangement, physiology, migration during development, and host immune responses. These proteins bind to their corresponding 7-membrane G-protein-coupled receptors. Chemokines and their receptors are anti-inflammatory factors in autoimmune conditions, so consider as potential targets for neutralization in such diseases. They also express by cancer cells and function as angiogenic factors, and/or survival/growth factors that enhance tumor angiogenesis and development. Among chemokines, the CXCL12/CXCR4 axis has significantly been studied in numerous cancers and autoimmune diseases. CXCL12 is a homeostatic chemokine, which is acts as an anti-inflammatory chemokine during autoimmune inflammatory responses. In cancer cells, CXCL12 acts as an angiogenic, proliferative agent and regulates tumor cell apoptosis as well. CXCR4 has a role in leukocyte chemotaxis in inflammatory situations in numerous autoimmune diseases, as well as the high levels of CXCR4, observed in different types of human cancers. These findings suggest CXCL12/CXCR4 as a potential therapeutic target for therapy of autoimmune diseases and open a new approach to targeted-therapy of cancers by neutralizing CXCL12 and CXCR4. In this paper, we reviewed the current understanding of the role of the CXCL12/CXCR4 axis in disease pathology and cancer biology, and discuss its therapeutic implications in cancer and diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
einuo完成签到,获得积分10
刚刚
AKYDXS完成签到,获得积分10
3秒前
昏睡的蟠桃应助Llllll采纳,获得200
3秒前
科研通AI2S应助hao采纳,获得10
3秒前
4秒前
4秒前
香蕉觅云应助阿湫采纳,获得10
5秒前
星辰大海应助星辰采纳,获得10
5秒前
阿卡宁完成签到,获得积分10
5秒前
lzw完成签到 ,获得积分10
5秒前
沉静烧仙草完成签到,获得积分20
6秒前
烟花应助嘉嘉琦采纳,获得10
6秒前
隐形曼青应助科研通管家采纳,获得10
6秒前
Hello应助科研通管家采纳,获得10
7秒前
Ava应助科研通管家采纳,获得10
7秒前
上官若男应助科研通管家采纳,获得10
7秒前
7秒前
赘婿应助科研通管家采纳,获得10
7秒前
烟花应助科研通管家采纳,获得10
7秒前
FashionBoy应助科研通管家采纳,获得10
7秒前
英俊的铭应助科研通管家采纳,获得10
7秒前
在水一方应助科研通管家采纳,获得10
7秒前
accepted应助科研通管家采纳,获得10
7秒前
脑洞疼应助科研通管家采纳,获得10
7秒前
7秒前
cdh1994应助kcmat采纳,获得10
7秒前
我是老大应助科研通管家采纳,获得10
7秒前
乐乐应助科研通管家采纳,获得10
7秒前
FashionBoy应助科研通管家采纳,获得10
7秒前
7秒前
上官若男应助科研通管家采纳,获得10
7秒前
7秒前
7秒前
7秒前
我是老大应助科研通管家采纳,获得30
7秒前
脑洞疼应助科研通管家采纳,获得20
8秒前
科目三应助科研通管家采纳,获得30
8秒前
8秒前
完美世界应助科研通管家采纳,获得10
8秒前
8秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038524
求助须知:如何正确求助?哪些是违规求助? 3576221
关于积分的说明 11374737
捐赠科研通 3305912
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892688
科研通“疑难数据库(出版商)”最低求助积分说明 815048